Development of a robust blood‐based multi‐pathway biomarker assay for early screening and classification of Alzheimer’s disease

Background Alzheimer's disease (AD) is a devastating neurodegenerative disease with delayed diagnosis until the manifestation of symptoms. Although the emergence of blood‐based biomarkers offers hope for easy detection of AD, existing AD‐associated blood biomarkers, known as the “blood ATN biom...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Alzheimer's & dementia 2024-12, Vol.20 (S2), p.n/a
Hauptverfasser:	Ouyang, Li, JIANG, Yuanbing, Uhm, Hyebin, Ip, Fanny C. F., Lo, Ronnie M.N., Cheng, Elaine Y.L., Cao, Xiaoyun, Tan, Clara M.C., Law, Brian C.H., Ortiz‐Romero, Paula, Puig‐Pijoan, Albert, Fernández‐Lebrero, Aida, Contador, José, Mok, Kin Y, Hardy, John A., Kwok, Timothy CY, Mok, Vincent Chung Tong, Suárez‐Calvet, Marc, Zetterberg, Henrik, Fu, Amy K.Y., Ip, Nancy Y.
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomarkers
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!